The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
The global Albendazole market was valued at US$ 148 million in 2020 and is expected to reach US$ 249.7 million by the end of 2027, growing at a CAGR of 7.8% during 2021-2027.
This report focuses on Albendazole volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Albendazole market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Albendazole Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Tablet
Capsule
Other
Segment by Application
Human
Veterinary
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
The global Albendazole market was valued at US$ 148 million in 2020 and is expected to reach US$ 249.7 million by the end of 2027, growing at a CAGR of 7.8% during 2021-2027.
This report focuses on Albendazole volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Albendazole market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Albendazole Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Tablet
Capsule
Other
Segment by Application
Human
Veterinary
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Index1 Albendazole Market Overview
1.1 Product Overview and Scope of Albendazole
1.2 Albendazole Segment by Type
1.2.1 Global Albendazole Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Albendazole Segment by Application
1.3.1 Global Albendazole Sales Comparison by Application: (2021-2027)
1.3.2 Human
1.3.3 Veterinary
1.4 Global Albendazole Market Size Estimates and Forecasts
1.4.1 Global Albendazole Revenue 2016-2027
1.4.2 Global Albendazole Sales 2016-2027
1.4.3 Albendazole Market Size by Region: 2016 Versus 2021 Versus 2027
2 Albendazole Market Competition by Manufacturers
2.1 Global Albendazole Sales Market Share by Manufacturers (2016-2021)
2.2 Global Albendazole Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Albendazole Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Albendazole Manufacturing Sites, Area Served, Product Type
2.5 Albendazole Market Competitive Situation and Trends
2.5.1 Albendazole Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Albendazole Players Market Share by Revenue
2.5.3 Global Albendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Albendazole Retrospective Market Scenario by Region
3.1 Global Albendazole Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Albendazole Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Albendazole Market Facts & Figures by Country
3.3.1 North America Albendazole Sales by Country
3.3.2 North America Albendazole Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Albendazole Market Facts & Figures by Country
3.4.1 Europe Albendazole Sales by Country
3.4.2 Europe Albendazole Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Albendazole Market Facts & Figures by Region
3.5.1 Asia Pacific Albendazole Sales by Region
3.5.2 Asia Pacific Albendazole Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Albendazole Market Facts & Figures by Country
3.6.1 Latin America Albendazole Sales by Country
3.6.2 Latin America Albendazole Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Albendazole Market Facts & Figures by Country
3.7.1 Middle East and Africa Albendazole Sales by Country
3.7.2 Middle East and Africa Albendazole Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Albendazole Historic Market Analysis by Type
4.1 Global Albendazole Sales Market Share by Type (2016-2021)
4.2 Global Albendazole Revenue Market Share by Type (2016-2021)
4.3 Global Albendazole Price by Type (2016-2021)
5 Global Albendazole Historic Market Analysis by Application
5.1 Global Albendazole Sales Market Share by Application (2016-2021)
5.2 Global Albendazole Revenue Market Share by Application (2016-2021)
5.3 Global Albendazole Price by Application (2016-2021)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Albendazole Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Huazhong Pharmaceutical
6.2.1 Huazhong Pharmaceutical Corporation Information
6.2.2 Huazhong Pharmaceutical Description and Business Overview
6.2.3 Huazhong Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Huazhong Pharmaceutical Albendazole Product Portfolio
6.2.5 Huazhong Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Qihui
6.3.1 Jiangsu Qihui Corporation Information
6.3.2 Jiangsu Qihui Description and Business Overview
6.3.3 Jiangsu Qihui Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Jiangsu Qihui Albendazole Product Portfolio
6.3.5 Jiangsu Qihui Recent Developments/Updates
6.4 Sequent Scientific
6.4.1 Sequent Scientific Corporation Information
6.4.2 Sequent Scientific Description and Business Overview
6.4.3 Sequent Scientific Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sequent Scientific Albendazole Product Portfolio
6.4.5 Sequent Scientific Recent Developments/Updates
6.5 K.A. Malle Pharmaceuticals
6.5.1 K.A. Malle Pharmaceuticals Corporation Information
6.5.2 K.A. Malle Pharmaceuticals Description and Business Overview
6.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.5.4 K.A. Malle Pharmaceuticals Albendazole Product Portfolio
6.5.5 K.A. Malle Pharmaceuticals Recent Developments/Updates
6.6 Lasa Supergenerics Limited
6.6.1 Lasa Supergenerics Limited Corporation Information
6.6.2 Lasa Supergenerics Limited Description and Business Overview
6.6.3 Lasa Supergenerics Limited Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Lasa Supergenerics Limited Albendazole Product Portfolio
6.6.5 Lasa Supergenerics Limited Recent Developments/Updates
6.7 Zhongjia Pharmaceutical
6.6.1 Zhongjia Pharmaceutical Corporation Information
6.6.2 Zhongjia Pharmaceutical Description and Business Overview
6.6.3 Zhongjia Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Zhongjia Pharmaceutical Albendazole Product Portfolio
6.7.5 Zhongjia Pharmaceutical Recent Developments/Updates
6.8 Fredun Pharmaceuticals Ltd
6.8.1 Fredun Pharmaceuticals Ltd Corporation Information
6.8.2 Fredun Pharmaceuticals Ltd Description and Business Overview
6.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Portfolio
6.8.5 Fredun Pharmaceuticals Ltd Recent Developments/Updates
6.9 Supharma Chem
6.9.1 Supharma Chem Corporation Information
6.9.2 Supharma Chem Description and Business Overview
6.9.3 Supharma Chem Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Supharma Chem Albendazole Product Portfolio
6.9.5 Supharma Chem Recent Developments/Updates
6.10 Salius Pharma
6.10.1 Salius Pharma Corporation Information
6.10.2 Salius Pharma Description and Business Overview
6.10.3 Salius Pharma Albendazole Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Salius Pharma Albendazole Product Portfolio
6.10.5 Salius Pharma Recent Developments/Updates
7 Albendazole Manufacturing Cost Analysis
7.1 Albendazole Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Albendazole
7.4 Albendazole Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Albendazole Distributors List
8.3 Albendazole Customers
9 Albendazole Market Dynamics
9.1 Albendazole Industry Trends
9.2 Albendazole Growth Drivers
9.3 Albendazole Market Challenges
9.4 Albendazole Market Restraints
10 Global Market Forecast
10.1 Albendazole Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Albendazole by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Albendazole by Type (2022-2027)
10.2 Albendazole Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Albendazole by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Albendazole by Application (2022-2027)
10.3 Albendazole Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Albendazole by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Albendazole by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Albendazole Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Albendazole Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Albendazole Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Albendazole Covered in This Study
Table 5. Global Albendazole Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Albendazole Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Albendazole Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Albendazole Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Albendazole Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Albendazole Manufacturing Sites and Area Served
Table 11. Manufacturers Albendazole Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Albendazole by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Albendazole as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Albendazole Sales by Region (2016-2021) & (K MT)
Table 16. Global Albendazole Sales Market Share by Region (2016-2021)
Table 17. Global Albendazole Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Albendazole Sales by Country (2016-2021) & (K MT)
Table 19. North America Albendazole Sales Market Share by Country (2016-2021)
Table 20. North America Albendazole Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Albendazole Revenue Market Share by Country (2016-2021)
Table 22. Europe Albendazole Sales by Country (2016-2021) & (K MT)
Table 23. Europe Albendazole Sales Market Share by Country (2016-2021)
Table 24. Europe Albendazole Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Albendazole Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Albendazole Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Albendazole Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Albendazole Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Albendazole Revenue Market Share by Region (2016-2021)
Table 30. Latin America Albendazole Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Albendazole Sales Market Share by Country (2016-2021)
Table 32. Latin America Albendazole Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Albendazole Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Albendazole Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Albendazole Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Albendazole Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Albendazole Revenue Market Share by Country (2016-2021)
Table 38. Global Albendazole Sales (K MT) by Type (2016-2021)
Table 39. Global Albendazole Sales Market Share by Type (2016-2021)
Table 40. Global Albendazole Revenue (Million US$) by Type (2016-2021)
Table 41. Global Albendazole Revenue Share by Type (2016-2021)
Table 42. Global Albendazole Price (USD/MT) by Type (2016-2021)
Table 43. Global Albendazole Sales (K MT) by Application (2016-2021)
Table 44. Global Albendazole Sales Market Share by Application (2016-2021)
Table 45. Global Albendazole Revenue (Million US$) by Application (2016-2021)
Table 46. Global Albendazole Revenue Share by Application (2016-2021)
Table 47. Global Albendazole Price (USD/MT) by Application (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Albendazole Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Huazhong Pharmaceutical Corporation Information
Table 54. Huazhong Pharmaceutical Description and Business Overview
Table 55. Huazhong Pharmaceutical Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Huazhong Pharmaceutical Albendazole Product
Table 57. Huazhong Pharmaceutical Recent Developments/Updates
Table 58. Jiangsu Qihui Corporation Information
Table 59. Jiangsu Qihui Description and Business Overview
Table 60. Jiangsu Qihui Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Jiangsu Qihui Albendazole Product
Table 62. Jiangsu Qihui Recent Developments/Updates
Table 63. Sequent Scientific Corporation Information
Table 64. Sequent Scientific Description and Business Overview
Table 65. Sequent Scientific Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Sequent Scientific Albendazole Product
Table 67. Sequent Scientific Recent Developments/Updates
Table 68. K.A. Malle Pharmaceuticals Corporation Information
Table 69. K.A. Malle Pharmaceuticals Description and Business Overview
Table 70. K.A. Malle Pharmaceuticals Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. K.A. Malle Pharmaceuticals Albendazole Product
Table 72. K.A. Malle Pharmaceuticals Recent Developments/Updates
Table 73. Lasa Supergenerics Limited Corporation Information
Table 74. Lasa Supergenerics Limited Description and Business Overview
Table 75. Lasa Supergenerics Limited Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Lasa Supergenerics Limited Albendazole Product
Table 77. Lasa Supergenerics Limited Recent Developments/Updates
Table 78. Zhongjia Pharmaceutical Corporation Information
Table 79. Zhongjia Pharmaceutical Description and Business Overview
Table 80. Zhongjia Pharmaceutical Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Zhongjia Pharmaceutical Albendazole Product
Table 82. Zhongjia Pharmaceutical Recent Developments/Updates
Table 83. Fredun Pharmaceuticals Ltd Corporation Information
Table 84. Fredun Pharmaceuticals Ltd Description and Business Overview
Table 85. Fredun Pharmaceuticals Ltd Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Fredun Pharmaceuticals Ltd Albendazole Product
Table 87. Fredun Pharmaceuticals Ltd Recent Developments/Updates
Table 88. Supharma Chem Corporation Information
Table 89. Supharma Chem Description and Business Overview
Table 90. Supharma Chem Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Supharma Chem Albendazole Product
Table 92. Supharma Chem Recent Developments/Updates
Table 93. Salius Pharma Corporation Information
Table 94. Salius Pharma Description and Business Overview
Table 95. Salius Pharma Albendazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Salius Pharma Albendazole Product
Table 97. Salius Pharma Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Albendazole Distributors List
Table 101. Albendazole Customers List
Table 102. Albendazole Market Trends
Table 103. Albendazole Growth Drivers
Table 104. Albendazole Market Challenges
Table 105. Albendazole Market Restraints
Table 106. Global Albendazole Sales Forecast by Type (2022-2027) & (K MT)
Table 107. Global Albendazole Sales Market Share Forecast by Type (2022-2027)
Table 108. Global Albendazole Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 109. Global Albendazole Revenue Market Share Forecast by Type (2022-2027)
Table 110. Global Albendazole Sales Forecast by Application (2022-2027) & (K MT)
Table 111. Global Albendazole Sales Market Share Forecast by Application (2022-2027)
Table 112. Global Albendazole Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 113. Global Albendazole Revenue Market Share Forecast by Application (2022-2027)
Table 114. Global Albendazole Sales Forecast by Region (2022-2027) & (K MT)
Table 115. Global Albendazole Sales Market Share Forecast by Region (2022-2027)
Table 116. Global Albendazole Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 117. Global Albendazole Revenue Market Share Forecast by Region (2022-2027)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Albendazole
Figure 2. Global Albendazole Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Other Product Picture
Figure 6. Global Albendazole Market Share by Application in 2020 & 2027
Figure 7. Human
Figure 8. Veterinary
Figure 9. Global Albendazole Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Albendazole Market Size 2016-2027 (US$ Million)
Figure 11. Global Albendazole Sales 2016-2027 (K MT)
Figure 12. Global Albendazole Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Albendazole Sales Share by Manufacturers in 2020
Figure 14. Global Albendazole Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Albendazole Players: Market Share by Revenue in 2020
Figure 16. Albendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Albendazole Sales Market Share by Region (2016-2021)
Figure 18. Global Albendazole Sales Market Share by Region in 2020
Figure 19. Global Albendazole Revenue Market Share by Region (2016-2021)
Figure 20. Global Albendazole Revenue Market Share by Region in 2020
Figure 21. U.S. Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Albendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Albendazole by Type (2016-2021)
Figure 44. Sales Market Share of Albendazole by Application (2016-2021)
Figure 45. Sales Market Share of Albendazole by Application in 2020
Figure 46. Revenue Share of Albendazole by Application (2016-2021)
Figure 47. Revenue Share of Albendazole by Application in 2020
Figure 48. Manufacturing Cost Structure of Albendazole
Figure 49. Manufacturing Process Analysis of Albendazole
Figure 50. Albendazole Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
